First successful use of ampicillin-sulbactam for rare Streptococcus agalactiae-associated peritonitis in peritoneal dialysis: a case report and literature review
This case represents the first documented success of intravenous ampicillin-sulbactam for <i>S. agalactiae</i>-associated peritonitis in PD. It expands the therapeutic options for this rare and challenging infection and highlights the importance of culture-guided management and adaptive treatment strategies, particularly in resource-limited settings where conventional intraperitoneal therapies may be unavailable.
Authors
- Juan S. Izquierdo‐Condoy (ORCID: https://orcid.org/0000-0002-1178-0546)
- Clara I. Berrocal
- Humberto Alejandro Nati-Castillo (ORCID: https://orcid.org/0000-0003-1890-4983)
- Luz Marina Mejía (ORCID: https://orcid.org/0009-0005-6142-4530)
- Alice Gaibor-Pazmiño (ORCID: https://orcid.org/0000-0002-2760-8791)
- J. M. Quintero-Romero
- A. Zapata-Aristizábal
Institutions
- Universidad de Las Américas (EC)
- Corporación Universitaria Empresarial Alexander von Humboldt (CO)
- Universidad Libre de Colombia (CO)
- Universidad del Valle (CO)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-02
- DOI
- https://doi.org/10.3389/fmed.2025.1652738
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00